HIV hides within immune system’s ‘police stations’

A new study finds that HIV hides within specialized fighter cells in the immune system, a crucial step towards eradicating the virus that causes AIDS.
Virus wearing police hat

(© stock.adobe.com)

Antiretroviral therapy (ART) is highly effective at controlling HIV infections, but the virus never completely goes away. Instead, it hides in roughly one in every 1 million immune cells.

Specifically, HIV hides within specialized cells known as cytotoxic CD4+ T cells, which are the immune system’s best fighters, a new study by Yale School of Medicine researchers found. These HIV-infected immune cells are able to shield themselves from being destroyed by other immune system cells.

Since CD4+ T cells also help kill cancer cells and control infections, identifying the virus-harboring cells may be a crucial step towards eradicating the virus that causes AIDS, researchers say.

The new study was published March 22 in the journal Immunity.

For the study, a team led by first author Jack Collora, a microbiology graduate student at Yale, used a cutting-edge technology called single-cell multi-omic sequencing to study HIV-infected cells of people living with HIV. Collora is a member of the lab of Ya-Chi Ho, associate professor of microbial pathogenesis and medicine.

The specialized cytotoxic CD4+ T cells where HIV cells hide also produce cancer-fighting proteins called Granzyme B, as well as a protein called Serpin B9 that acts as a shield that protects then from being damaged by toxic proteins. However, when HIV hides behind these well-shielded fighters, the immune system cannot eliminate HIV-infected cells.

These cells are like police stations protecting our body against cancer and infection,” said Ho, the senior author of the study. “The problem is, how do we kill HIV without damaging these key immune system fighters? The goal is not to remove police stations, but to find out why there are expanding numbers of police stations where HIV can hide.”

Researchers had previously understood that HIV-infected individuals have higher levels of inflammation, a condition known as chronic antigen stimulation, which increases the number of potentially HIV-hiding T cells.

One immediate solution to rooting out hidden HIV is to control chronic antigen stimulation in people living with HIV,” Ho said. “When these pathogen dangers are gone, the body would naturally downsize the number of police stations and shrink the number of hiding places for HIV.”

Finding an ultimate cure that kills the HIV-infected cells without harming the uninfected cells remains elusive, Ho said. Further studies are necessary to determine how to enable the body to kill these infected cells, or to remove them through traditional treatments.

Ho participates actively in five National Institutes of Health (NIH) multi-center collaborations — REACH, BEAT-HIV, M-SCORCH, Y-SCORCH, and CHEETAH Structural Biology Center — to speed up basic science discoveries and develop HIV cure strategies. She will bring their latest understanding of the advanced basic science of HIV infection to the think tank of the American Foundation for AIDS Research where she and researchers will brainstorm and aim to improve immunotherapy for an HIV cure.

Other Yale authors in the new study include David van Dijk and Serena Spudich. Ann Duerr at Fred Hutchinson Cancer Center and Luis Montaner at Wistar Institute are also co-authors.

This study was supported by the NIH, the American Foundation for AIDS Research, Gilead HIV Scholar, Yale Top Scholar, and the Yale COVID Gap Fund.

Share this with Facebook Share this with Twitter Share this with LinkedIn Share this with Email Print this

Media Contact

Bess Connolly : elizabeth.connolly@yale.edu,